Five-day regimen of azacitidine for lower-risk myelodysplastic syndromes (refractory anemia or refractory anemia with ringed sideroblasts): A prospective single-arm phase 2 trial
about
Five-day regimen of azacitidine for lower-risk myelodysplastic syndromes (refractory anemia or refractory anemia with ringed sideroblasts): A prospective single-arm phase 2 trial
description
im Oktober 2018 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 26 August 2018
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 2018
@uk
name
Five-day regimen of azacitidin ...... ctive single-arm phase 2 trial
@en
Five-day regimen of azacitidine for lower-risk myelodysplastic syndromes
@nl
type
label
Five-day regimen of azacitidin ...... ctive single-arm phase 2 trial
@en
Five-day regimen of azacitidine for lower-risk myelodysplastic syndromes
@nl
prefLabel
Five-day regimen of azacitidin ...... ctive single-arm phase 2 trial
@en
Five-day regimen of azacitidine for lower-risk myelodysplastic syndromes
@nl
P2093
P2860
P356
P1433
P1476
Five-day regimen of azacitidin ...... ctive single-arm phase 2 trial
@en
P2093
Fumiaki Urase
Hirohiko Shibayama
Hitoshi Hanamoto
Itaru Matsumura
Kazuo Tsubaki
Shuhei Kawata
Terufumi Yamaguchi
Yasuhiro Maeda
Yasuyoshi Morita
P2860
P304
P356
10.1111/CAS.13739
P407
P577
2018-08-26T00:00:00Z